Bruker also announced a strategic partnership with Switzerland-based Biognosys AG earlier in January 2023. The collaboration is expected to create unique synergies between Biognosys' versatile portfolio of proprietary proteomics services, software and kits and Bruker's pioneering timsTOF platform.